Dr Edward Humphries will be presenting at the Sophion Japanese User meeting on Friday 11th October to be held at the Knowledge Capital Conference Rooms at the Grand Front, Osaka.
Edd’s talk is entitled: “Advancing Cardiac Safety Screening on the QPatch”
Edd will be at the User meeting all day and will be available to offer an overview of Metrion’s ion channel drug discovery services. Please contact email@example.com if you would like to arrange a meeting with Edd.
Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focused upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from once off screening projects to fully integrated drug discovery programmes delivering clinical candidates.